TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Gate Bioscience Announces $65 Million Oversubscribed Series B Financing to Advance Oral Molecular Gate Medicines into the Clinic

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Jordi Mata-Fink
Gate Bioscience Announces $65 Million Oversubscribed Series B Financing to Advance Oral Molecular Gate Medicines into the Clinic

Gate Bioscience raised $65 million in an oversubscribed Series B financing led by Forbion and Eli Lilly to advance its molecular gate medicine platform targeting inflammatory and neurological diseases through oral small molecule therapies.

Insights
MA   positive

Beat earnings expectations, 15% year-over-year revenue growth, expanding into AI and crypto services, and near-universal analyst Buy ratings (27/29 Buy recommendations)


LLY   neutral

Participated as a new investor, showing cautious interest in the company's potential without full commitment